Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
MEDSECUREAN.COM

2. Address

Address1
74 Windy Hollow Court
 Address2
​
City
Great Falls
 State
VA
 Zip Code
22066
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Ms.
​Kathleen Jaeger
​7034248049
​kjaeger@medsecurean.com
5. Senate ID#
​401108536-60141
7. Client Name Self Check if client is a state or local government or instrumentality
​Indian Pharmaceutical Association
6. House ID#
​565120001
TYPE OF REPORT 8. Year
​2024
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​15,000.00
$5,000 or more $
​
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Kathleen Jaeger
 Date
5/10/2024 10:16:59 AM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Derisking the Affordable Medicine Supply Chain (KSMs, APIs), seeking a US-India trade partnership that can be expanded to other trusted allies. Partnership concept includes industry sustainability, quality metrics, market demand, domestic and allied manufacturing, suite of financial tools among others. During this quarter, only engaged in outreach to set up meetings for a CEO delegation Fly-In for Late April.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Natl Security Council (NSC), Health & Human Services - Dept of (HHS), White House Office, U.S. Trade Representative (USTR), State - Dept of (DOS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Kathleen
Jaeger
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​Indian Pharmaceutical Association is a trade association in India, representing key innovative and affordable medicine manufacturers. These manufacturers supply nearly 50% of Medicare Prescriptions, and of the top 10 US therapeutic categories, the companies supply more than half of the prescriptions for 5 of the top 10 categories-ranging up to 60%.

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TRD

16. Specific lobbying issues

Derisking the Affordable Medicine Supply Chain (KSMs, APIs), seeking a US-India trade partnership that can be expanded to other trusted allies. Partnership concept includes industry sustainability, quality metrics, market demand, domestic and allied manufacturing, suite of financial tools among others. During this quarter, only engaged in outreach to set up meetings for a CEO delegation Fly-In for Late April.

17. House(s) of Congress and Federal agencies Check if None

U.S. Trade Representative (USTR), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, State - Dept of (DOS), Natl Security Council (NSC)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Kathleen
Jaeger
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​Indian Pharmaceutical Asociation is a trade association in India, representing innovative and affordable medicine manufacturers.

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code DEF

16. Specific lobbying issues

Derisking the Affordable Medicine Supply Chain (KSMs, APIs), seeking a US-India trade partnership that can be expanded to other trusted allies. Partnership concept includes industry sustainability, quality metrics, market demand, domestic and allied manufacturing, suite of financial tools among others. During this quarter, only engaged in outreach to set up meetings for a CEO delegation Fly-In for Late April.

17. House(s) of Congress and Federal agencies Check if None

Natl Security Council (NSC), Food & Drug Administration (FDA)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Kathleen
Jaeger
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​Indian Pharmaceutical Association is a trade association in India, representing innovative and affordable medicine manufacturers who supply nearly half of the affordable medicine used in the U.S.

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HOM

16. Specific lobbying issues

Derisking the Affordable Medicine Supply Chain (KSMs, APIs), seeking a US-India trade partnership that can be expanded to other trusted allies. Partnership concept includes industry sustainability, quality metrics, market demand, domestic and allied manufacturing, suite of financial tools among others. During this quarter, only engaged in outreach to set up meetings for a CEO delegation Fly-In for Late April.

17. House(s) of Congress and Federal agencies Check if None

Natl Security Council (NSC)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Kathleen
Jaeger
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​Indian Pharmaceutical Association is a trade association in India, representing innovative and affordable medicine manufacturers who supply the U.S. with nearly 50% of affordable medicine used in the U.S.

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)